Mainstream

Plus Therapeutics GAAP EPS of -$0.01 beats by $0.07, revenue of $1.39M misses by $0.44M

Plus Therapeutics GAAP EPS of -$0.01 beats by $0.07, revenue of $1.39M misses by $0.44M

Post ContentpstvRead More

You might also be interested in reading Intellicheck signals expanded sales push and AWS migration progress while retail revenue declines 26%.

August 15, 2025
In Mainstream